久久国产综合一区二区,亚洲精品国产a9999,日韩欧美国产综合在线一区二区三区,黄色av大片在线免费观看

Products

Products

Detail

Wan Ling Wu Xiang Gao

Wan Ling Wu Xiang Gao


Approval No.

SFDA approval number Z33020534

Prescription Features

Promoting blood circulation to remove meridian obstruction, relieving swelling and pain.

Indications

1. Injuries from falls, soft tissue injury, muscle strain;
2. Periarthritis of shoulder, chondritis, synovitis, tenosynovitis and other aseptic inflammations.
3. Theumatic arthritis, rheumatoid arthritis, injury of joint, swelling.

Properties

This product is black paste spread on clith or yellowish-brown powder in a small bottle.

Ingredients

Musk, nux vomica, Radix Aconiti Kusenzoffii, pangolin, frankincense, myrrh, peach kernel, red flower, root of common peony, Ligusticum wallichii, teasel root, etc.

Functions and Indications

Promoting blood circulation to remove meridian obstruction, relieving swelling and pain. In the therapy of arthralgia, injuries from falls, etc.

Usage and dosage

For external use, warming and softening, pour the medicine powder in the vial into the center of the plaster, stick it on the affected area.

Packing

10g×1 sheet, 0.25g×1 bottle; 15g×1 sheet, 0.38g×1 bottle
20g×1 sheet, 0.25g×2 bottles; 30g×1 sheet, 0.38g×2 bottles

Specifications

Net weight is 20g, 0.25g/bottle (2 bottles)

Notes

Pregnant women should not stick to the waist and abdomen.

Storage

Tightly sealed and kept in cool and dry place.

Clinical Verifications

Zhejiang Sports Commission, Zhejiang Institute of Physicians and Zhejiang Institute of Physical Hygiene jointly observed the efficacy of Ling Wu Xiang Gao in the treatment of 312 athletes' sports trauma. The results showed that the total effective rate was 96%, the apparent efficiency was 69%, and the cure rate was 31%. .

【Back】

 Email Login       Search | Manager

Copyright(C)2018, HangZhou Zhuyangxin Pharmaceutical Co.,LTD All Rights Reserved. Supported by ChemNet ChinaChemNet Toocle Copyright Notice

| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |